SCHEMBL4974375

SCHEMBL4974375

CC1(O)CCN(c2nc(Cl)nc(Cl)c2F)CC1.COCC(Oc1nc(Cl)nc(N2CCC(C)(O)CC2)c1F)c1ncc(F)cc1F

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.36
JAK3 P52333 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4985706 0.84 JAK2 (0.58) JAK2JAK3
SCHEMBL4974705 0.84 JAK2 (0.49) JAK2JAK3
SCHEMBL4971410 0.80 JAK2 (0.36) JAK2JAK3
SCHEMBL4978667 0.79 JAK3 (0.62) JAK2JAK3
SCHEMBL4972492 0.77 JAK2 (0.36) JAK2JAK3
SCHEMBL4972260 0.77
SCHEMBL4972541 0.74 JAK2 (0.46) JAK2JAK3
SCHEMBL4972192 0.73 SMN1; SMN2 (0.31)
SCHEMBL4974714 0.73 JAK2 (0.47) JAK2JAK3
SCHEMBL4972475 0.72 CNR2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008132502-A1 PYRAZOLYL-AMINO-SUBSTITUTED PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-11-06 WO disclosed